Approaching the Asymptote? Evolution and Revolution in Immunology, Cold Spring Harbor Symposia on Quantitative Biology, vol.54, issue.0, pp.1-13, 1989. ,
DOI : 10.1101/SQB.1989.054.01.003
Toll-like receptors and innate immunity, Nature Reviews Immunology, vol.274, issue.2, pp.135-145, 2001. ,
DOI : 10.1074/jbc.274.19.12955
Establishment of dorsal-ventral polarity in the Drosophila embryo: Genetic studies on the role of the Toll gene product, Cell, vol.42, issue.3, p.779, 1985. ,
DOI : 10.1016/0092-8674(85)90274-0
The Dorsoventral Regulatory Gene Cassette sp??tzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults, Cell, vol.86, issue.6, pp.973-983, 1996. ,
DOI : 10.1016/S0092-8674(00)80172-5
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity, Nature, vol.254, issue.6640, pp.394-397, 1997. ,
DOI : 10.1126/science.1925582
How dying cells alert the immune system to danger, Nature Reviews Immunology, vol.171, issue.4, pp.279-289, 2008. ,
DOI : 10.4049/jimmunol.171.1.398
TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY, Shock, vol.32, issue.1, pp.4-16, 2009. ,
DOI : 10.1097/SHK.0b013e318193e333
The TREM receptor family and signal integration, Nature Immunology, vol.20, issue.12, pp.1266-1273, 2006. ,
DOI : 10.1096/fj.05-5646com
The human TREM gene cluster at 6p21.1 encodes both activating and inhibitory single IgV domain receptors and includes NKp44, European Journal of Immunology, vol.33, issue.2, pp.567-577, 2003. ,
DOI : 10.1002/immu.200310033
Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes, The Journal of Immunology, vol.164, issue.10, pp.4991-4995, 2000. ,
DOI : 10.4049/jimmunol.164.10.4991
The TREM-1/DAP12 pathway, Immunology Letters, vol.116, issue.2, pp.111-116, 2008. ,
DOI : 10.1016/j.imlet.2007.11.021
TREM-1 amplifies inflammation and is a crucial mediator of septic shock, Nature, vol.410, issue.6832, pp.1103-1107, 2001. ,
DOI : 10.1038/35074114
Surface and soluble triggering receptor expressed on myeloid cells-1: Expression patterns in murine sepsis, Critical Care Medicine, vol.33, issue.8, pp.1787-1793, 2005. ,
DOI : 10.1097/01.CCM.0000172614.36571.75
TREM-1) at 1.47 Å, Crystal Structure of Human Triggering Receptor Expressed on Myeloid Cells J Mol Biol, vol.1342, pp.1237-1248, 2004. ,
Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients, Clinical and Experimental Immunology, vol.171, issue.3, pp.448-455, 2006. ,
DOI : 10.4049/jimmunol.171.2.594
TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans, Journal of Clinical Investigation, vol.119, issue.6, p.1489, 2009. ,
DOI : 10.1172/JCI36175DS1
Soluble Trem-like Transcript-1 Regulates Leukocyte Activation and Controls Microbial Sepsis, The Journal of Immunology, vol.188, issue.11, pp.5585-5592, 2012. ,
DOI : 10.4049/jimmunol.1102674
URL : http://www.jimmunol.org/content/jimmunol/188/11/5585.full.pdf
Cardiovascular disease in Europe 2014: epidemiological update, European Heart Journal, vol.60, issue.42, pp.2950-2959, 2014. ,
DOI : 10.1016/j.jacc.2012.08.962
URL : https://academic.oup.com/eurheartj/article-pdf/35/42/2950/17354923/ehu299.pdf
Estimation of Infarct Size in Man and its Relation to Prognosis, Circulation, vol.46, issue.4, pp.640-648, 1972. ,
DOI : 10.1161/01.CIR.46.4.640
Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction, Investigators, FAST MI Investigators, pp.998-1006, 2000. ,
DOI : 10.1001/2012.jama.11348
Hospitalization for congestive heart failure: United States, NCHS Data Brief, pp.1-8, 2000. ,
Myocardial Reperfusion Injury, New England Journal of Medicine, vol.357, issue.11, p.1121, 2007. ,
DOI : 10.1056/NEJMra071667
URL : https://hal.archives-ouvertes.fr/hal-01608633
Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog, Arch Pathol, vol.70, pp.68-78, 1960. ,
Functional and clinical repercussions of myocyte apoptosis in the multifaceted damage by ischemia/reperfusion injury: old and new concepts after 10 years of contributions, Cell Death and Differentiation, vol.11, pp.144-152, 2004. ,
DOI : 10.1038/sj.cdd.4401544
Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury, J Biol Chem, vol.263, pp.1353-1357, 1988. ,
from mitochondria, The FASEB Journal, vol.17, issue.15, pp.2202-2208, 2003. ,
DOI : 10.1016/S0959-440X(03)00008-3
Myocardial ischaemia and reperfusion ??? pathophysiological aspects, R??animation, vol.20, issue.S2, pp.267-273, 2010. ,
DOI : 10.1007/s13546-010-0102-5
Cardiac remodeling???concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling, Journal of the American College of Cardiology, vol.35, issue.3, pp.569-582, 2000. ,
DOI : 10.1016/S0735-1097(99)00630-0
Cellular mechanisms of myocardial infarct expansion, Circulation, vol.78, issue.1, pp.186-201, 1988. ,
DOI : 10.1161/01.CIR.78.1.186
Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities, Heart Failure Reviews, vol.121, issue.19, pp.13-21, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.108.808071
The Mechanistic Basis of Infarct Healing, Antioxidants & Redox Signaling, vol.8, issue.11-12, pp.1907-1939, 2006. ,
DOI : 10.1089/ars.2006.8.1907
The Immune System and the Remodeling Infarcted Heart, Journal of Cardiovascular Pharmacology, vol.63, issue.3, pp.185-195, 2014. ,
DOI : 10.1097/FJC.0000000000000003
Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice, Acta Physiologica Scandinavica, vol.145, issue.1, pp.75-82, 2001. ,
DOI : 10.1016/S0959-437X(98)80068-3
The role of matrix metalloproteinases in heart disease, Cardiovascular Research, vol.32, issue.5, pp.816-821, 1996. ,
DOI : 10.1016/S0008-6363(96)00104-6
Evolution and clinical implications of the myofibroblast concept, Cardiovascular Research, vol.38, issue.3, pp.545-548, 1998. ,
DOI : 10.1016/S0008-6363(98)00065-0
The role of myocardial fibrillar collagen in ventricular remodeling and function, Journal of Cardiac Failure, vol.8, issue.6, pp.319-325, 2002. ,
DOI : 10.1054/jcaf.2002.129260
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function, Physiological Reviews, vol.87, issue.4, pp.1285-1342, 2007. ,
DOI : 10.1152/ajpheart.00160.2004
Blockade of NF-??B improves cardiac function and survival without affecting inflammation in TNF-??-induced cardiomyopathy, Cardiovascular Research, vol.66, issue.3, pp.520-529, 2005. ,
DOI : 10.1016/j.cardiores.2005.02.007
The Role of Interleukin-1 in the Failing Heart, Heart Fail Rev, vol.6, pp.81-94, 2001. ,
DOI : 10.1007/978-1-4615-1449-7_3
Abnormal cardiac wall motion and early matrix metalloproteinase activity, American Journal of Physiology-Heart and Circulatory Physiology, vol.288, issue.3, pp.1080-1087, 2005. ,
DOI : 10.1074/jbc.273.11.6550
Osteopontin Induces Nuclear Factor ??B-mediated Promatrix Metalloproteinase-2 Activation through I??B??/IKK Signaling Pathways, and Curcumin (Diferulolylmethane) Down-regulates These Pathways, Journal of Biological Chemistry, vol.163, issue.16, pp.14487-14497, 2003. ,
DOI : 10.3109/00498259609046741
URL : http://www.jbc.org/content/278/16/14487.full.pdf
Matricellular Proteins as Modulators of Cell-Matrix Interactions: Adhesive Defect in Thrombospondin 2-null Fibroblasts is a Consequence of Increased Levels of Matrix Metalloproteinase-2, Molecular Biology of the Cell, vol.11, issue.10, pp.3353-3364, 2000. ,
DOI : 10.1091/mbc.11.10.3353
Transforming Growth Factor-?? Repression of Matrix Metalloproteinase-1 in Dermal Fibroblasts Involves Smad3, Journal of Biological Chemistry, vol.14, issue.42, pp.38502-38510, 2001. ,
DOI : 10.1038/29814
In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1., Journal of Clinical Investigation, vol.102, issue.11, pp.2002-2010, 1998. ,
DOI : 10.1172/JCI2881
Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts, Molecular and Cellular Biochemistry, vol.229, issue.suppl II, pp.13-21, 1996. ,
DOI : 10.1161/01.RES.67.1.23
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure, Nature Medicine, vol.267, issue.10, pp.1135-1142, 1999. ,
DOI : 10.1126/science.7863332
Region- and Type-Specific Induction of Matrix Metalloproteinases in Post-Myocardial Infarction Remodeling, Circulation, vol.107, issue.22, pp.2857-2863, 2003. ,
DOI : 10.1161/01.CIR.0000068375.40887.FA
Myocardial Infarct Expansion and Matrix Metalloproteinase Inhibition, Circulation, vol.107, issue.4, pp.618-625, 2003. ,
DOI : 10.1161/01.CIR.0000046449.36178.00
URL : http://circ.ahajournals.org/content/circulationaha/107/4/618.full.pdf
Selective Targeting of Matrix Metalloproteinase Inhibition in Post-Infarction Myocardial Remodeling, Journal of Cardiovascular Pharmacology, vol.47, issue.2, pp.228-235, 2006. ,
DOI : 10.1097/01.fjc.0000200989.23987.b8
Effects of Selective Matrix Metalloproteinase Inhibitor (PG-116800) to Prevent Ventricular Remodeling After Myocardial Infarction, Journal of the American College of Cardiology, vol.48, issue.1, pp.15-20, 2006. ,
DOI : 10.1016/j.jacc.2006.02.055
Clinical and Biochemical Results of the Metalloproteinase Inhibition with Subantimicrobial Doses of Doxycycline to Prevent Acute Coronary Syndromes (MIDAS) Pilot Trial, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.4, pp.733-738, 2004. ,
DOI : 10.1161/01.ATV.0000121571.78696.dc
A pathway and network review on beta-adrenoceptor signaling and beta blockers in cardiac remodeling, Heart Failure Reviews, vol.65, issue.6, pp.799-814, 2014. ,
DOI : 10.1016/j.freeradbiomed.2013.06.033
Differential effects of isoproterenol on the activity of angiotensin-converting enzyme in the rat heart and aorta, Brazilian Journal of Medical and Biological Research, vol.24, issue.3, pp.355-360, 1999. ,
DOI : 10.1161/01.HYP.8.12.1154
Effects of Carvedilol on Left Ventricular Remodeling After Acute Myocardial Infarction: The CAPRICORN Echo Substudy, Circulation, vol.109, issue.2, pp.201-206, 2004. ,
DOI : 10.1161/01.CIR.0000108928.25690.94
Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure, Journal of the American College of Cardiology, vol.36, issue.7, pp.2072-2080, 2000. ,
DOI : 10.1016/S0735-1097(00)01006-8
Extracellular Cardiac Matrix Biomarkers in Patients With Acute Myocardial Infarction Complicated by Left Ventricular Dysfunction and Heart Failure: Insights From the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Study, Circulation, vol.119, issue.18, pp.2471-2479, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.809194
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators, SOLVD Investigators, pp.431-438, 1992. ,
DOI : 10.1161/01.CIR.86.2.431
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure : Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study: The RESOLVD Pilot Study Investigators, Circulation, vol.100, issue.10, pp.1056-1064, 1999. ,
DOI : 10.1161/01.CIR.100.10.1056
Aldosterone Receptor Antagonism Induces Reverse Remodeling When Added to Angiotensin Receptor Blockade in Chronic Heart Failure, Journal of the American College of Cardiology, vol.50, issue.7, pp.591-596, 2007. ,
DOI : 10.1016/j.jacc.2007.03.062
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC, Eur Heart J, vol.33, pp.1787-1847, 2012. ,
Regulation of the Inflammatory Response in Cardiac Repair, Circulation Research, vol.110, issue.1, pp.159-173, 2012. ,
DOI : 10.1161/CIRCRESAHA.111.243162
High-Mobility Group Box-1 in Ischemia-Reperfusion Injury of the Heart, Circulation, vol.117, issue.25, pp.3216-3226, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.108.769331
The innate immune response in reperfused myocardium, Cardiovascular Research, vol.293, issue.4, pp.276-283, 2012. ,
DOI : 10.1152/ajpheart.00776.2007
Inhibition of Mannose-Binding Lectin Reduces Postischemic Myocardial Reperfusion Injury, Circulation, vol.104, issue.12, pp.1413-1418, 2001. ,
DOI : 10.1161/hc3601.095578
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis, Science, vol.249, issue.4965, pp.146-151, 1990. ,
DOI : 10.1126/science.2371562
Reactive oxygen species, cell signaling, and cell injury, Free Radical Biology and Medicine, vol.28, issue.10, pp.1456-1462, 2000. ,
DOI : 10.1016/S0891-5849(00)00252-5
Reactive oxygen species promote angiogenesis in the infarcted rat heart, International Journal of Experimental Pathology, vol.28, issue.6, pp.621-629, 2009. ,
DOI : 10.1159/000115289
Multiple Facets of NF-??B in the Heart, Circulation Research, vol.108, issue.9, pp.1122-1132, 2011. ,
DOI : 10.1161/CIRCRESAHA.110.226928
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse, Proceedings of the National Academy of Sciences, vol.293, issue.3, pp.19725-19730, 2011. ,
DOI : 10.1152/ajpheart.00291.2007
Inflammasome Activation of Cardiac Fibroblasts Is Essential for Myocardial Ischemia/Reperfusion Injury, Circulation, vol.123, issue.6, pp.594-604, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.110.982777
Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-??, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/Reperfusion, Circulation, vol.98, issue.7, pp.699-710, 1998. ,
DOI : 10.1161/01.CIR.98.7.699
Divergent Tumor Necrosis Factor Receptor-Related Remodeling Responses in Heart Failure: Role of Nuclear Factor-??B and Inflammatory Activation, Circulation, vol.119, issue.10, pp.1386-1397, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.802918
Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects, British Journal of Pharmacology, vol.280, issue.6 Suppl, pp.414-427, 2008. ,
DOI : 10.4049/jimmunol.178.8.4832
Continuous Glycoprotein-130-Mediated Signal Transducer and Activator of Transcription-3 Activation Promotes Inflammation, Left Ventricular Rupture, and Adverse Outcome in Subacute Myocardial Infarction, Circulation, vol.122, issue.2, pp.145-155, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.109.933127
The immune system and cardiac repair, Pharmacological Research, vol.58, issue.2, pp.88-111, 2008. ,
DOI : 10.1016/j.phrs.2008.06.007
Plasma Concentrations of Myeloperoxidase Predict Mortality After Myocardial Infarction, Journal of the American College of Cardiology, vol.49, issue.20, pp.1993-2000, 2007. ,
DOI : 10.1016/j.jacc.2007.02.040
Proteinase 3 and prognosis of patients with acute myocardial infarction, Clinical Science, vol.120, issue.6, pp.231-238, 1979. ,
DOI : 10.1042/CS20100366
URL : https://hal.archives-ouvertes.fr/hal-00647879
VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia/reperfusion injury in mice, Blood, vol.123, issue.1, pp.141-148, 2014. ,
DOI : 10.1182/blood-2013-07-514992
Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps, Journal of Thrombosis and Haemostasis, vol.86, issue.12, pp.2074-2088, 2014. ,
DOI : 10.1016/S0049-3848(97)00096-0
Phagocyte partnership during the onset and resolution of inflammation, Nature Reviews Immunology, vol.8, issue.6, pp.427-439, 2010. ,
DOI : 10.4049/jimmunol.180.10.6868
Role of interleukin-6 in regulation of immune responses to remodeling after myocardial infarction, Heart Failure Reviews, vol.367, issue.1, pp.25-38, 2015. ,
DOI : 10.1056/NEJMoa1112802
Endoscopic Time-Lapse Imaging of Immune Cells in Infarcted Mouse Hearts, Circulation Research, vol.112, issue.6, pp.891-899, 2013. ,
DOI : 10.1161/CIRCRESAHA.111.300484
Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure, Science, vol.339, issue.6116, pp.161-166, 2013. ,
DOI : 10.1126/science.1230720
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions, The Journal of Experimental Medicine, vol.52, issue.12, pp.3037-3047, 2007. ,
DOI : 10.1007/BF00788278
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites, Science, vol.25, issue.3, pp.612-616, 2009. ,
DOI : 10.1016/0002-9343(88)90206-9
Cardiac macrophages and their role in ischaemic heart disease, Cardiovascular Research, vol.34, issue.11 Suppl 1, pp.240-248, 2014. ,
DOI : 10.1093/eurheartj/ehs366
Inflammatory signals regulate hematopoietic stem cells, Trends in Immunology, vol.32, issue.2, pp.57-65, 2011. ,
DOI : 10.1016/j.it.2010.12.003
URL : http://europepmc.org/articles/pmc3042730?pdf=render
Cellular Immunity and Cardiac Remodeling After Myocardial Infarction: Role of Neutrophils, Monocytes, and Macrophages, Current Heart Failure Reports, vol.34, issue.1 Pt 2, pp.247-254, 2015. ,
DOI : 10.1093/eurheartj/ehs366
Ly-6Chigh Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium, Circulation Research, vol.114, issue.10, pp.1611-1622, 2014. ,
DOI : 10.1161/CIRCRESAHA.114.303204
Role of Lymphocytes in Myocardial Injury, Healing, and Remodeling After Myocardial Infarction, Circulation Research, vol.116, issue.2, pp.354-367, 2015. ,
DOI : 10.1161/CIRCRESAHA.116.304072
B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction, Nature Medicine, vol.360, issue.10, pp.1273-1280, 2013. ,
DOI : 10.1056/NEJMoa0808227
URL : http://europepmc.org/articles/pmc4042928?pdf=render
Myocardial Infarct-Sparing Effect of Adenosine A2A Receptor Activation Is due to Its Action on CD4+ T Lymphocytes, Circulation, vol.114, issue.19, pp.2056-2064, 2006. ,
DOI : 10.1161/CIRCULATIONAHA.106.649244
Activation of CD4+ T Lymphocytes Improves Wound Healing and Survival After Experimental Myocardial Infarction in Mice, Circulation, vol.125, issue.13, pp.1652-1663, 2012. ,
DOI : 10.1161/CIRCULATIONAHA.111.044164
Foxp3+ CD4+ T Cells Improve Healing After Myocardial Infarction by Modulating Monocyte/Macrophage Differentiation, Circulation Research, vol.115, issue.1, 2014. ,
DOI : 10.1161/CIRCRESAHA.115.303895
URL : http://circres.ahajournals.org/content/circresaha/115/1/55.full.pdf
Granzyme B degrades extracellular matrix and contributes to delayed wound closure in apolipoprotein E knockout mice, Cell Death & Differentiation, vol.4, issue.10, pp.1404-1414, 2013. ,
DOI : 10.1002/prot.340040306
Elevation of Plasma Granzyme B Levels After Acute Myocardial Infarction, Circulation Journal, vol.73, issue.3, pp.503-507, 2009. ,
DOI : 10.1253/circj.CJ-08-0668
Cytotoxic T Lymphocytes Are Activated Following Myocardial Infarction and Can Recognize and Kill Healthy Myocytes In Vitro, Journal of Molecular and Cellular Cardiology, vol.32, issue.12, pp.2141-2149, 2000. ,
DOI : 10.1006/jmcc.2000.1261
Enhanced Efferocytosis of Apoptotic Cardiomyocytes Through Myeloid-Epithelial-Reproductive Tyrosine Kinase Links Acute Inflammation Resolution to Cardiac Repair After Infarction, Circulation Research, vol.113, issue.8, pp.1004-1012, 2013. ,
DOI : 10.1161/CIRCRESAHA.113.301198
Regulatory T cells are recruited in the infarcted mouse myocardium and may modulate fibroblast phenotype and function, American Journal of Physiology-Heart and Circulatory Physiology, vol.142, issue.8, pp.1233-1242, 2014. ,
DOI : 10.1038/nm.3284
Inhibition of TGF-? signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction, Cardiovascular Research, vol.64, issue.3, pp.526-535, 2004. ,
DOI : 10.1016/j.cardiores.2004.07.017
GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice, Nature Medicine, vol.146, issue.5, pp.581-588, 2011. ,
DOI : 10.1084/jem.20072660
The Chemokine Decoy Receptor D6 Prevents Excessive Inflammation and Adverse Ventricular Remodeling After Myocardial Infarction, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.9, pp.2206-2213, 2012. ,
DOI : 10.1161/ATVBAHA.112.254409
URL : http://atvb.ahajournals.org/content/atvbaha/32/9/2206.full.pdf
Endogenous IRAK-M Attenuates Postinfarction Remodeling Through Effects on Macrophages and Fibroblasts, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.32, issue.11, pp.2598-2608, 2012. ,
DOI : 10.1161/ATVBAHA.112.300310
URL : http://atvb.ahajournals.org/content/atvbaha/32/11/2598.full.pdf
Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction, Journal of the American College of Cardiology, vol.63, issue.16, pp.1593-1603, 2014. ,
DOI : 10.1016/j.jacc.2014.01.014
URL : https://doi.org/10.1016/j.jacc.2014.01.014
Double-Blind, Randomized Trial of an Anti-CD18 Antibody in Conjunction With Recombinant Tissue Plasminogen Activator for Acute Myocardial Infarction: Limitation of Myocardial Infarction Following Thrombolysis in Acute Myocardial Infarction (LIMIT AMI) Study, Circulation, vol.104, issue.23, pp.2778-2783, 2001. ,
DOI : 10.1161/hc4801.100236
The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study, Journal of the American College of Cardiology, vol.40, issue.7, pp.1199-1204, 2002. ,
DOI : 10.1016/S0735-1097(02)02136-8
Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) Trial, Circulation, vol.108, issue.10, pp.1176-1183, 2003. ,
DOI : 10.1161/01.CIR.0000087404.53661.F8
Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial, Circulation, vol.108, issue.10, pp.1184-1190, 2003. ,
DOI : 10.1161/01.CIR.0000087447.12918.85
Van de Werf F, others. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial, JAMA J Am Med Assoc, vol.297, p.43, 2007. ,
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Adenosine as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction (AMISTAD-II), Journal of the American College of Cardiology, vol.45, issue.11, pp.1775-1780, 2005. ,
DOI : 10.1016/j.jacc.2005.02.061
Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial, European Heart Journal, vol.27, issue.20, pp.2400-2405, 2006. ,
DOI : 10.1093/eurheartj/ehl094
Acute adenosinergic cardioprotection in ischemic-reperfused hearts, American Journal of Physiology-Heart and Circulatory Physiology, vol.285, issue.5, pp.1797-1818, 2003. ,
DOI : 10.1161/01.CIR.88.5.2359
Inflammation in cardiac injury, repair and regeneration, Current Opinion in Cardiology, vol.30, issue.3, pp.240-245, 2015. ,
DOI : 10.1097/HCO.0000000000000158
Myocardial Ischemia/Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti-Toll-Like Receptor-2 Antibody, Circulation, vol.121, issue.1, pp.80-90, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.109.880187
Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice, Circulation, vol.109, issue.6, pp.784-789, 2004. ,
DOI : 10.1161/01.CIR.0000112575.66565.84
Steroid controversy in sepsis and septic shock, Critical Care Medicine, vol.23, issue.7, p.1294, 1995. ,
DOI : 10.1097/00003246-199507000-00021
Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients, Critical Care Medicine, vol.29, issue.3, p.503, 2001. ,
DOI : 10.1097/00003246-200103000-00006
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group, JAMA: The Journal of the American Medical Association, vol.271, issue.23, pp.1836-1843, 1994. ,
DOI : 10.1001/jama.271.23.1836
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis, JAMA, vol.309, issue.11, pp.1154-1162, 2013. ,
DOI : 10.1001/jama.2013.2194
Risk and the Efficacy of Antiinflammatory Agents, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.9, pp.1197-1205, 2002. ,
DOI : 10.1172/JCI112902
Effects of a TREM-Like Transcript 1???Derived Peptide During Hypodynamic Septic Shock in Pigs, Shock, vol.39, issue.2, pp.176-182, 2013. ,
DOI : 10.1097/SHK.0b013e31827bcdfb
URL : https://hal.archives-ouvertes.fr/hal-01272749
Targeting the Inflammatory Response in Healing Myocardial Infarcts, Current Medicinal Chemistry, vol.13, issue.16, pp.1877-1893, 2006. ,
DOI : 10.2174/092986706777585086
The inflammatory response in myocardial injury, repair and remodelling, Nature Reviews Cardiology, vol.147, issue.5, pp.255-265, 2014. ,
DOI : 10.1016/j.trsl.2012.01.023
A Soluble Form of the Triggering Receptor Expressed on Myeloid Cells-1 Modulates the Inflammatory Response in Murine Sepsis, The Journal of Experimental Medicine, vol.10, issue.11, pp.1419-1426, 2004. ,
DOI : 10.7326/0003-4819-141-1-200407060-00009
Attenuation of Responses to Endotoxin by the Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor LR12 in Nonhuman Primate, Anesthesiology, vol.120, issue.4, pp.935-942, 2014. ,
DOI : 10.1097/ALN.0000000000000078
URL : https://hal.archives-ouvertes.fr/hal-01738448
TREM-1 Deficiency Can Attenuate Disease Severity without Affecting Pathogen Clearance Available from, PLoS Pathog, vol.10, 2014. ,
DOI : 10.1371/journal.ppat.1003900
URL : https://doi.org/10.1371/journal.ppat.1003900
Transepithelial migration of neutrophils into the lung requires TREM-1, Journal of Clinical Investigation, vol.123, issue.1, pp.138-149, 2013. ,
DOI : 10.1172/JCI64181DS1
Usefulness of Fetuin-A and C-Reactive Protein Concentrations for Prediction of Outcome in Acute Coronary Syndromes (from the French Registry of Acute ST-Elevation Non-ST-Elevation Myocardial Infarction [FAST-MI]), The American Journal of Cardiology, vol.111, issue.1, pp.31-37, 2013. ,
DOI : 10.1016/j.amjcard.2012.08.042
Genetic Determinants of Response to Clopidogrel and Cardiovascular Events, New England Journal of Medicine, vol.360, issue.4, pp.363-375, 2009. ,
DOI : 10.1056/NEJMoa0808227
Targeting inflammatory pathways in myocardial infarction, European Journal of Clinical Investigation, vol.87, issue.9, pp.986-995, 2013. ,
DOI : 10.1161/01.CIR.87.2.526
Myocardial reperfusion injury: looking beyond primary PCI, European Heart Journal, vol.55, issue.23, pp.1714-1722, 2013. ,
DOI : 10.1016/j.jacc.2009.10.052
Bridging Innate Immunity and Myocardial Ischemia/Reperfusion Injury: The Search for Therapeutic Targets, Current Pharmaceutical Design, vol.14, issue.12, pp.1205-1216, 2008. ,
DOI : 10.2174/138161208784246090
Innate immune signaling in cardiac ischemia, Nature Reviews Cardiology, vol.182, issue.5, pp.292-300, 2011. ,
DOI : 10.4049/jimmunol.0803842
Toll-Like Receptors and Myocardial Inflammation, International Journal of Inflammation, vol.169, issue.6, p.170352, 2011. ,
DOI : 10.1097/ALN.0b013e31820a4d78
Modulation of the Triggering Receptor Expressed on Myeloid Cells???1 Pathway during Pneumonia in Rats, The Journal of Infectious Diseases, vol.194, issue.7, pp.975-983, 2006. ,
DOI : 10.1086/506950
Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis, Journal of Hepato-Biliary-Pancreatic Sciences, vol.187, issue.3, pp.305-312, 2010. ,
DOI : 10.1086/374754
EFFECTS OF THE TREM 1 PATHWAY MODULATION DURING HEMORRHAGIC SHOCK IN RATS, Shock, vol.32, issue.6, p.633, 2009. ,
DOI : 10.1097/SHK.0b013e3181a53842
TREM-1???expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases, Journal of Clinical Investigation, vol.117, issue.10, pp.3097-3106, 2007. ,
DOI : 10.1172/JCI30602DS1
Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.68, issue.11, pp.1768-1774, 2009. ,
DOI : 10.1136/ard.2008.089557
Increased gingival crevicular fluid levels of soluble triggering receptor expressed on myeloid cells (sTREM) -1 in severe periodontitis, Journal of Clinical Periodontology, vol.36, issue.53, pp.1141-1148, 2012. ,
DOI : 10.1097/CCM.0b013e31817b8824
Deleterious effects of methylprednisolone in patients with myocardial infarction, Circulation, vol.53, pp.204-206, 1976. ,
Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock, Translational Research, vol.156, issue.5, pp.273-281, 2010. ,
DOI : 10.1016/j.trsl.2010.07.011
Myocardial infarction and intramyocardial injection models in swine, Nature Protocols, vol.3, issue.8, pp.1479-1496, 2012. ,
DOI : 10.1016/S0735-1097(99)00126-6
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry, Journal of the American College of Cardiology, vol.44, issue.2, pp.340-348, 2004. ,
DOI : 10.1016/j.jacc.2004.03.060
Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study], Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling TrialVCU-ART2) Pilot Study], pp.1394-1400, 2013. ,
DOI : 10.1016/j.amjcard.2013.01.287
Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies, Cardiovascular Research, vol.74, issue.3, pp.343-355, 2007. ,
DOI : 10.1016/j.cardiores.2007.01.014
Immunomodulation in the critically ill, British Journal of Anaesthesia, vol.103, issue.1, pp.70-81, 2009. ,
DOI : 10.1093/bja/aep128
Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing, Journal of Molecular Medicine, vol.55, issue.4, pp.361-369, 2012. ,
DOI : 10.1016/j.jacc.2009.06.059
A genomic storm in critically injured humans, The Journal of Experimental Medicine, vol.61, issue.13, pp.2581-2590, 2011. ,
DOI : 10.1038/nature08780
The role of neutrophils in myocardial ischemia???reperfusion injury, Cardiovascular Research, vol.43, issue.4, pp.860-878, 1999. ,
DOI : 10.1016/S0008-6363(99)00187-X
Mechanisms of neutrophil-induced parenchymal cell injury, Journal of Leukocyte Biology, vol.61, issue.6, pp.647-653, 1997. ,
DOI : 10.1002/jlb.61.6.647
Immune Cell Toll-Like Receptor 4 Is Required for Cardiac Myocyte Impairment During Endotoxemia, Circulation Research, vol.95, issue.7, pp.700-707, 2004. ,
DOI : 10.1161/01.RES.0000144175.70140.8c
URL : http://circres.ahajournals.org/content/circresaha/95/7/700.full.pdf
Reactive Oxygen Species in Myocardial Reperfusion Injury: From Physiopathology to Therapeutic Approaches, Current Pharmaceutical Biotechnology, vol.13, issue.1, pp.97-114, 2012. ,
DOI : 10.2174/138920112798868782
: a sensitive, continuous, load-independent contractility index, Experimental Physiology, vol.287, issue.10, pp.1446-1456, 2013. ,
DOI : 10.1152/ajpheart.00624.2003
URL : http://onlinelibrary.wiley.com/doi/10.1113/expphysiol.2013.073833/pdf